Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
S. 3384 Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020 03/03/2020 Sen. Martha McSally (R-AZ) 03/03/2020 Referred to Committee on Finance Allows HHS to negotiate prices for certain Medicare Part D drugs. Allows individuals to import drugs from Canada. S. 3166 Prescription Drug Affordability and Access Act 01/08/2020 Sen.
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
S. 3384 Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020 03/03/2020 Sen. Martha McSally (R-AZ) 03/03/2020 Referred to Committee on Finance Allows HHS to negotiate prices for certain Medicare Part D drugs. Allows individuals to import drugs from Canada. S. 3166 Prescription Drug Affordability and Access Act 01/08/2020 Sen.
Among its various attempts to regulate drug prices, the Trump administration recently sought to force pharmaceutical advertisements to disclose the wholesale acquisition cost (WAC) of certain drugs. This effort was dealt a setback in June, when the D.C. Circuit found that the Department of Health and Human Services (HHS) overstepped its regulatory authority by compelling disclosure of these costs. Merck & Co., Inc. v. U.S. Dep’t Health & Human Servs. (“Merck”).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
